medRxiv
An experimental model of clinical immunity for human malaria
Plasmodium vivax attenuates systemic inflammation to promote immunity against febrile malaria
Under review; preprint at medRxiv
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection
Plasmodium falciparum attenuates cytotoxic T cells to promote immunity against severe malaria
Published in J Exp Med
Journal of Experimental Medicine
The Journal of Clinical Investigation
A systematic analysis of the human immune response to Plasmodium vivax
Cytotoxic T cells cause tissue damage and injury in malaria
Published in J Clin Invest.
Inducible mechanisms of disease tolerance provide an alternative strategy of acquired immunity to malaria
Malaria remodels the spleen to imprint disease tolerance
Published in eLife
eLIFE
eLife
Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum
Immune variation determines clinical outcome in malaria
Published in eLife
Vector transmission regulates immune control of Plasmodium virulence
Mosquitoes regulate malaria disease severity
Published in Nature
Nature